Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 03, 2025

Get In Touch

Koselugo approved in EU for plexiform neurofibromas in adults with neurofibromatosis type 1: AstraZeneca Pharma News

Koselugo approved in EU for plexiform neurofibromas in adults with neurofibromatosis type 1: AstraZeneca

  • 29 October 2025
  • 4 days ago

FDA Approves Tezspire for Chronic Rhinosinusitis with Nasal Polyps ENT

FDA Approves Tezspire for Chronic Rhinosinusitis with Nasal Polyps

  • 24 October 2025
  • 1 week ago

AstraZeneca Tezspire approved in EU for chronic rhinosinusitis with nasal polyps Pharma News

AstraZeneca Tezspire approved in EU for chronic rhinosinusitis with nasal polyps

  • 23 October 2025
  • 1 week ago

AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus Pharma News

AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus

  • 20 October 2025
  • 1 week ago

AstraZeneca-Amgen Tezspire gets USFDA nod for chronic rhinosinusitis with nasal polyps Pharma News

AstraZeneca-Amgen Tezspire gets USFDA nod for chronic rhinosinusitis with nasal polyps

  • 18 October 2025
  • 2 weeks ago

Baxdrostat Shows Significant Blood Pressure Reduction in Resistant Hypertension in Phase III trial Medicine

Baxdrostat Shows Significant Blood Pressure Reduction in Resistant Hypertension in Phase III trial

  • 16 October 2025
  • 2 weeks ago

AstraZeneca Gets SEC Nod for New Trastuzumab Deruxtecan Indication in HER2-Positive Solid Tumors Pharma News

AstraZeneca Gets SEC Nod for New Trastuzumab Deruxtecan Indication in HER2-Positive Solid Tumors

  • 10 October 2025
  • 3 weeks ago

AstraZeneca to harmonise its listing structure across LSE, STO and NYSE Pharma News

AstraZeneca to harmonise its listing structure across LSE, STO and NYSE

  • 30 September 2025
  • 1 month ago

AstraZeneca Koselugo recommended for approval in EU for plexiform neurofibromas in adults with neurofibromatosis type 1 Pharma News

AstraZeneca Koselugo recommended for approval in EU for plexiform neurofibromas in adults with neurofibromatosis type 1

  • 28 September 2025
  • 1 month ago

Patent infringement: Factor Bioscience sues AstraZeneca, Cellectis over gene-editing technology Pharma News

Patent infringement: Factor Bioscience sues AstraZeneca, Cellectis over gene-editing technology

  • 27 September 2025
  • 1 month ago

Recent News

GLP-1 Receptor Agonists Linked to Lower Risk of Ea...

  • 03 November, 2025

Ketogenic diet may protect against stress experien...

  • 03 November, 2025

STORM-PE Trial: Mechanical Thrombectomy Shows Supe...

  • 03 November, 2025

AIIMS INI CET January 2026 admit cards released

  • 03 November, 2025

3 pharma students drown in Payyambalam beach in Ke...

  • 03 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.